Interlace Medical

Framingham, United States Founded: 2006 • Age: 20 yrs Acquired By Hologic
Gynecological devices for office-based procedures are designed and developed.
Request Access

About Interlace Medical

Interlace Medical is a company based in Framingham (United States) founded in 2006 was acquired by Hologic in January 2011.. Interlace Medical has raised $32.5 million across 3 funding rounds from investors including Hologic, New Leaf Venture Partners and Tekla Capital Management. Interlace Medical operates in a competitive market with competitors including Gynesonics, Channel Medsystems, Minerva Surgical, nVision Medical and Yingzi Medical, among others.

  • Headquarter Framingham, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Interlace Medical, Inc
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $32.5 M (USD)

    in 3 rounds

  • Latest Funding Round
    $20.5 M (USD), Series C

    Jun 15, 2009

  • Investors
    Hologic

    & 6 more

  • Employee Count
    Employee Count
  • Acquired by
    Hologic

    (Jan 07, 2011)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Interlace Medical

Interlace Medical has successfully raised a total of $32.5M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $20.5 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series C — $20.5M
  • First Round

    (21 May 2007)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2009 Amount Series C - Interlace Medical Valuation Baird Capital
Jul, 2008 Amount Series B - Interlace Medical Valuation

investors

May, 2007 Amount Series A - Interlace Medical Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Interlace Medical

Interlace Medical has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Hologic, New Leaf Venture Partners and Tekla Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
VC firm investing in expansion stage tech and life sciences companies in the US
Founded Year Domain Location
Stage-agnostic investments in US life sciences are managed.
Founded Year Domain Location
Global private equity and venture capital investments in B2B Tech & Services companies.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Interlace Medical

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Interlace Medical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Interlace Medical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Interlace Medical

Interlace Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gynesonics, Channel Medsystems, Minerva Surgical, nVision Medical and Yingzi Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
A minimally invasive ablation system for uterine fibroids is developed.
domain founded_year HQ Location
Cryothermic technology for endometrial ablation to control heavy bleeding
domain founded_year HQ Location
Minerva Surgical is focused on uterine health solutions.
domain founded_year HQ Location
Medical devices for women's health and infertility treatment are developed.
domain founded_year HQ Location
Manufacturer of minimally invasive gynecological medical devices and systems. The company develops and produces a range of products for hysteroscopic procedures, cervical health management, female rehabilitation, and gynecological diagnostics. These products are designed to improve clinical outcomes and enhance the patient experience. The company also provides medical training programs to support the use of its technologies.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Interlace Medical

Hologic Acquires Interlace Medical
Prnewswire15 years ago

Frequently Asked Questions about Interlace Medical

When was Interlace Medical founded?

Interlace Medical was founded in 2006 and raised its 1st funding round 1 year after it was founded.

Where is Interlace Medical located?

Interlace Medical is headquartered in Framingham, United States. It is registered at Framingham, Massachusetts, United States.

Is Interlace Medical a funded company?

Interlace Medical is a funded company, having raised a total of $32.5M across 3 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on May 21, 2007.

What does Interlace Medical do?

Interlace Medical was founded in 2006 in Framingham, United States, within the medical devices sector focused on gynecology. Devices are developed for interventional gynecologists to enable office-based treatments for conditions such as submucosal fibroids and polyps, reducing the need for operating room surgeries. Key products include the MyoSure hysteroscopic tissue removal system. The company was acquired by Hologic in January 2011.

Who are the top competitors of Interlace Medical?

Interlace Medical's top competitors include Gynesonics, Channel Medsystems and Minerva Surgical.

Who are Interlace Medical's investors?

Interlace Medical has 7 investors. Key investors include Hologic, New Leaf Venture Partners, Tekla Capital Management, HLM Venture Partners, and Baird Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available